- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05564195
Cognitive Trajectories After Surgery, a Clinical, Observational Feasibility Study (POCOR)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim is to evaluate the digital cognitive monitoring (Mindmore-P) in clinical practice by:
I) Test recruitment process and measure attrition rate. II) To establish whether it is possible to detect early signs of neurocognitive decline, using a digital postoperative cognitive screening tool i.e. Mindmore-P.
III) To investigate if there are any associations between choice of anesthetic drugs, delirium, duration of anesthesia, preoperative frailty, depression symptoms, postoperative delirium, physical function, and early postoperative recovery.
IV) Determine the usability and feasibility of Mindmore-P. V) Determine patients' experiences of early cognitive recovery in relation to signs of cognitive decline or no signs measured bythe four tests included in Mindmore-P
METHODS AND ANALYSIS Study design This is an observational feasibility study.
Participants included will be patients undergoing planned non-cardiac surgery with general anesthesia (n=50) at a hospital in Stockholm, Sweden. The sample size is based on the incidence of early cognitive decline at 1-2 weeks postoperatively of approximately 13-25%.
Inclusion criteria:
- >60 years of age undergoing elective non-cardiac surgery with general anesthesia.
- Duration of surgery >60 minutes
- Mini-mental state examination (MMSE) score >24.
Exclusion criteria:
- Unable to read and speak Swedish
- Uncorrected severe visual or auditory disorder, disease of the central nervous system, psychiatric diseases including alcoholism or drug dependence, current motor impairment in dominant hand, or colour-blindness.
Recruitment At the patient's preoperative anaesthesia consultation, a research nurse will provide oral and written information about the study. The details of the study and its potential benefits as well as risks will be explained carefully to the patient. If the patient agrees to participate in the study, they will undergo a MMSE screening to examine if they are eligible for the study.
Outcomes, look below.
Analysis Descriptive statistics of demographic data will be presented with number, percentage, and mean (sd) or min-max, as appropriate. As recommended by Borchers et al review from 2021, mild POCD (1-2 standard deviation [sd]) and major POCD (>2 sd) will be specified for each test result and POCD is present if at least two tests indicates decline.
Usability and attrition rates will be presented with descriptive statistics. Preoperative depression (GDS), frailty (CFS), postoperative recovery (SwQoR), functional status (WHODAS) will be compared between the groups, using Kruskal Wallis ANOVA followed by Mann-Whitney U-test and a Bonferroni correction. To analyse intraindividual differences over time in cognitive performance, the same statistical tests will be used as well as multivariate logistic regression analysis. A p-value of <0.05 will be statistically significant in all analyses, Qualitative data will be analysed with thematic analysis.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ulrica Nilsson, Professor
- Phone Number: 0046 8 524 838 22
- Email: ulrica.nilsson@ki.se
Study Contact Backup
- Name: Anahita Amirpour, MSc
- Email: anahita.amirpour@ki.se
Study Locations
-
-
-
Stockholm, Sweden, 141 83
- Recruiting
- Ulrica Nilsson
-
Contact:
- Ulrica Nilsson, Prof
- Email: ulrica.nilsson@ki.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- >60 years of age undergoing elective non-cardiac surgery with general anesthesia.
- Duration of surgery >60 minutes
- Mini-mental state examination score >24.
Exclusion Criteria:
- Mini-mental state examination, cut-off score of <23 indicating cognitive impairment
- Unable to read and speak Swedish
- Uncorrected severe visual or auditory disorder,
- Disease of the central nervous system
- Psychiatric diseases
- Alcoholism or drug dependence
- Current motor impairment in dominant hand
- Colour-blindness.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients undergoing elective surgery with a duration of > 60 minutes
Participants included will be patients undergoing planned non-cardiac surgery with general anesthesia that are >60 years of age, have a Mini-mental state examination score of >24, are able to speak Swedish and does not suffer from uncorrected severe visual or auditory disorder, disease of the central nervous system, psychiatric diseases including alcoholism or drug dependence, current motor impairment in dominant hand, or colour-blindness.
|
Digital cognitive tests - Mindmore-P, will be used to assess neurocognitive capacity and includes tests of verbal episodic memory, executive functions, visuospatial function and attention.
The cognitive tests are self-administered on a touch screen tablet (10.1" 20-30 min Windows).
The Mindmore-P is a web-application running on a full-screen Chrome browser.
The test is administered by using a capacitive touchscreen with features that record detailed information such as timing, pauses, and lifting of finger from the touchscreen.
Speech recognition is used in the screening of verbal memory and language.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment process and attrition rate
Time Frame: Through study completion, an average of 8 months
|
Number of possible participants vs. number of participants who accept to participate and number of participants who complete the study
|
Through study completion, an average of 8 months
|
|
Changes in postoperative cognitive function, part 1
Time Frame: Before surgery and day 1 or 2, and 3 weeks after surgery
|
Consortium to Establish a Registry for Alzheimer´s Disease (CERAD) A 10-word verbal learning test with 3 learning trials, a recall trial after ~7 min.
|
Before surgery and day 1 or 2, and 3 weeks after surgery
|
|
Changes in postoperative cognitive function, part 2
Time Frame: Before surgery and day 1 or 2, and 3 weeks after surgery
|
Trail Making Test (TMT- A & B), consisting of of 25 circles with letters or numbers on the screen. 4. Symbol Digits Processing Test (SDPT).The test consist of nine symbol-digit pairings at the top of the screen, one symbol in the middle of the screen, and a number grid at the bottom of the screen. |
Before surgery and day 1 or 2, and 3 weeks after surgery
|
|
Changes in postoperative cognitive function, part 3
Time Frame: Before surgery and day 1 or 2, and 3 weeks after surgery
|
Stroop Colour-Word Test (SCW).
24 words spelling out a the name of a colour which is printed in contrasting ink colours (e.g., the word "green" printed with red ink), and the participant is asked to tell the printed colour of the word rather than the word rather than the actual meaning of the word.
|
Before surgery and day 1 or 2, and 3 weeks after surgery
|
|
Changes in postoperative cognitive function, part 4
Time Frame: Before surgery and day 1 or 2, and 3 weeks after surgery
|
Symbol Digits Processing Test (SDPT).The test consist of nine symbol-digit pairings at the top of the screen, one symbol in the middle of the screen, and a number grid at the bottom of the screen.
|
Before surgery and day 1 or 2, and 3 weeks after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frailty
Time Frame: Before surgery
|
Clinical Frailty Scale, including 9-item ranging from 1 - very vital to 9 - terminally ill.
|
Before surgery
|
|
Signs of and changes in depression
Time Frame: Before surgery and 3 weeks after surgery
|
Geriatric Depression Scale (GDS), consisting of 15 items to be answered with Yes or No.
A score of 5 to 10 indicates probable depression and a score of more than 10 indicates definite depression.
|
Before surgery and 3 weeks after surgery
|
|
Changes in functional capacity
Time Frame: Before surgery and 3 weeks after surgery
|
World Health Organization Disability Assessment Schedule 2.0 (WHODAS), thats consists of 12-item.
Sum score ranges from 0-48, with increasing scores reflecting increasing disability
|
Before surgery and 3 weeks after surgery
|
|
Changes in postoperative recovery
Time Frame: Before surgery and day 1 or 2, and 3 weeks after surgery
|
Swedish version of Quality of Recovery, SwQoR, including 24 different postoperative symptoms to be rated on 11-point numerical scales from 0, "none of the time", to 10, "all of the time" Global score ranging from 0, "excellent quality of postoperative recovery," to 240, "extremely poor quality of recovery," with cutoff values of less than 31 at day 7 and less than 21 at day 14 indicating good recovery
|
Before surgery and day 1 or 2, and 3 weeks after surgery
|
|
Usability of Mindmore-P
Time Frame: 3 weeks after surgery
|
System Usability Scale (SUS), consisting of 10 items to be answered on a 5-point scale from "strongly agree" to "strongly disagree".
|
3 weeks after surgery
|
|
Feasibility and patients' experiences of early postoperative cognitive recovery
Time Frame: One month after surgery
|
Semi-structured, one-on-one interviews exploring patients' experiences of being assessed for cognitive performance and using Mindmore-P including assessment of facilitators and barriers, will be conducted.
The participants will be asked to communicate freely on their experiences of their postoperative recovery.
|
One month after surgery
|
|
Signs of and changes in postoperative delirium
Time Frame: After surgery twice a day on postoperative day 1-2
|
Nursing Delirium Screening Scale NU-DESC, an observational five-item scale where symptoms delirium are rated from 0 to 2. A score of 2 or more indicates delirium
|
After surgery twice a day on postoperative day 1-2
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ulrica Nilsson, Professor, Karolinska Insitutet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-03593-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.